Development and Evaluation of a Preoperative Risk Calculator for Periprosthetic Joint Infection Following Total Joint Arthroplasty.
Timothy L Tan, Mitchell G Maltenfort, Antonia F Chen...
https://pubmed.ncbi.nlm.nih.gov/29715226/Actively Recruiting
Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-04
70
Participants Needed
2
Research Sites
104 weeks
Total Duration
Researchers are investigating a new prosthesis coated with bacteriostatic silver to see if it can reduce infections that occur around joint implants after surgery. These infections, called periprosthetic joint infections, are serious complications leading to many revision surgeries, especially in patients at higher risk like the elderly, diabetics, immunocompromised individuals, or those with prior infections. This observational study aims to understand whether the silver coating effectively lowers the occurrence of these infections. The study involves patients receiving either a prosthesis with the silver coating or one without it. Participants include those awaiting second-stage surgery after an infection or patients scheduled for primary prosthetic surgery who have recurrent infections in other body areas. Researchers will monitor patients over time to compare infection rates and safety of the silver-coated devices. Throughout the study, participants will have follow-up assessments at 1, 3, 6, 12, and 24 months after surgery. These visits will evaluate the number of infections, safety profiles of the silver coating, clinical scores related to patient outcomes, integration of the implant, and any complications. The goal is to gather detailed information on how well the silver-coated prosthesis performs in preventing infections and ensuring patient safety over two years.
CONDITIONS
Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections
M
Matteo Romagnoli, MD
M
Maria Sartori, Phd
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituto Ortopedico Rizzoli
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day 0 (baseline)
Participants receive a prosthesis device, either silver-coated or not, as part of their routine care.
1 visit (in-person) for device implantation
Duration - 24 months
Participants are monitored for infections, clinical scores, osteointegration, complications, and safety of the silver-coated device over time.
Visits at 1 month, 3 months, 6 months, 12 months, and 24 months follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Timothy L Tan, Mitchell G Maltenfort, Antonia F Chen...
https://pubmed.ncbi.nlm.nih.gov/29715226/Maria Anna Smolle, Marko Bergovec, Susanne Scheipl...
https://pubmed.ncbi.nlm.nih.gov/35906279/Guido Scoccianti, Filippo Frenos, Giovanni Beltrami...
https://pubmed.ncbi.nlm.nih.gov/27523624/Ittai Shichman, Mackenzie Roof, Neil Askew...
https://pubmed.ncbi.nlm.nih.gov/36864906/Seref Akay, Anan Yaghmur
https://pubmed.ncbi.nlm.nih.gov/38474684/Xionggang Chen, Jianhong Zhou, Yu Qian...
https://pubmed.ncbi.nlm.nih.gov/36896412/Istituto Ortopedico Rizzoli
Lead Sponsor